Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
NCT00818948
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Nephritis
Systemic Lupus Erythematosus
Interventions
DRUG:
AMG 811
Sponsor
Amgen